- New weight loss pill that’s beating oral Ozempic NewsNation
- New weight loss pill beats oral Ozempic in major trial ScienceDaily
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment The New England Journal of Medicine
- Elecoglipron, a GLP-1 tablet, lowers blood glucose and bodyweight in phase 2b trial Labmate Online
- New weight-loss pill outperforms rival in major trial Qazinform
